Atomo NewsGet the app

Get the latest Science News and Discoveries

Efficacy endpoint changes in glioblastoma phase II clinical trials and the factors contributing to these changes - EurekAlert


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of clinical trials

clinical trials

Photo of factors

factors

Photo of endpoint changes

endpoint changes

Related news:

News photo

Tiny exosome couriers rewrite the healing code — RNA delivery sparks a new era in ischemic disease treatment - EurekAlert

News photo

How movement affects the way the brain processes sound and sight - EurekAlert

News photo

THz have many targets in a living cell and can treat cancer - EurekAlert

« Tiny exosome couriers rewrite the healing code — RNA delivery sparks a new era in ischemic disease treatment - EurekAlert
Regional role in the discrepancy of Hadley circulation intensity trends between reanalysis data and models - EurekAlert »